Context Therapeutics Presents CTIM-76 Phase 1 Trial in Progress at ASCO 2025
Context Therapeutics Inc. (NASDAQ:CNTX) is one of the best penny stocks under $1 to buy now.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | BioImpact Capital Mpm Capital | 14,705,882 | $9,000,000 | 1.55% | |
2. | Avidity Partners Management David Witzke And Michael Gregory | 7,477,200 | $4,576,046 | 0.87% | |
3. | Deep Track Capital David Kroin | 7,419,355 | $4,540,645 | 0.15% | |
4. | Great Point Partners Jeffrey Jay And David Kroin | 4,683,711 | $2,866,431 | 1.52% | |
5. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 1,935,484 | $1,196,807 | 0.05% |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$0.70 | 100,000 | $70,080.00 | 920,190 | 2025-06-09 | Filing | |
$0.58 | 20,000 | $11,520.00 | 29,000 | 2025-06-06 | Filing | |
$0.64 | 40,010 | $25,486.37 | 80,010 | 2025-06-06 | Filing | |
$0.84 | 5,823 | $4,900.05 | 159,701 | 2023-02-21 | Filing | |
$0.87 | 5,606 | $4,900.77 | 153,878 | 2023-02-13 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 57,804 | $37,873 | 0% |